Inhibition of the spliceosome impairs survival, tumorigenicity and metastasis of MYC-dependent breast cancer.49 Therefore, we inferred that COMMD6 may regulate tumorigenesis and development through ribonucleoprotein and spliceosome complex biogenesis. This evidence concerns the gene COMMD6 and breast carcinoma.